Fundz

SERB Pharmaceuticals

Paris, Ile-de-France, France · Biotechnology, Health Care, Manufacturing

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB has the broadest antidote portfolio in the world, including med

Key facts

Headquarters
Paris, Ile-de-France, France
Employees
120
Industries
Biotechnology, Health Care, Manufacturing
Status
Private
Website
serb.com
LinkedIn
Company page

Recent activity at SERB Pharmaceuticals

Leadership

  • Arthur Pignot, Chief Strategy Officer
  • Vignesh Rajah, Chief Medical Officer

Verified email and direct lines for SERB Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

SERB Pharmaceuticals in the news

Companies similar to SERB Pharmaceuticals

About SERB Pharmaceuticals: questions and answers

What does SERB Pharmaceuticals do?

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB has the broadest antidote portfolio in the world, including med

Where is SERB Pharmaceuticals headquartered?

SERB Pharmaceuticals is headquartered in Paris, Ile-de-France, France.

How many employees does SERB Pharmaceuticals have?

SERB Pharmaceuticals has about 120 employees.

What is the latest news on SERB Pharmaceuticals?

On Nov 17, 2025, SERB Pharmaceuticals Appoints Dr. Vignesh Rajah as Chief Medical Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches SERB Pharmaceuticals across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.